- MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
-
Kaneko E, Sato N, Sugawara T, Noto A, Takahashi K, Makino K, Terada Y
- KMID: 2526276
- J Gynecol Oncol.
- 2021 Nov;32(6):e79.
- doi: 10.3802/jgo.2021.32.e79
Objective The antitumor effects of anti-PD-1 antibody against mismatch repair deficiency (MMR-D)-associated cancers have been reported. MMR-D is found in approximately 20%–30% of endometrial carcinomas (ECs) and frequently occurs due to... -
- CITED
-
- Close
- SHARE
-
- Close
